Synergistic reduction in albuminuria in type 2 diabetic mice by esaxerenone (CS-3150), a novel nonsteroidal selective mineralocorticoid receptor blocker, combined with an angiotensin II receptor blocker
Arai, Kiyoshi, Morikawa, Yuka, Ubukata, Naoko, Sugimoto, Kotaro
Published in Hypertension research (01.11.2020)
Published in Hypertension research (01.11.2020)
Get full text
Journal Article
Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist
Arai, Kiyoshi, Homma, Tsuyoshi, Morikawa, Yuka, Ubukata, Naoko, Tsuruoka, Hiyoyuki, Aoki, Kazumasa, Ishikawa, Hirokazu, Mizuno, Makoto, Sada, Toshio
Published in European journal of pharmacology (15.08.2015)
Published in European journal of pharmacology (15.08.2015)
Get full text
Journal Article
ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice
Terasaka, Naoki, Miyazaki, Atsuhiro, Kasanuki, Naomi, Ito, Kayoko, Ubukata, Naoko, Koieyama, Tadashi, Kitayama, Ken, Tanimoto, Tatsuo, Maeda, Naoyuki, Inaba, Toshimori
Published in Atherosclerosis (01.02.2007)
Published in Atherosclerosis (01.02.2007)
Get full text
Journal Article
CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats
Arai, Kiyoshi, Morikawa, Yuka, Ubukata, Naoko, Tsuruoka, Hiroyuki, Homma, Tsuyoshi
Published in The Journal of pharmacology and experimental therapeutics (01.09.2016)
Published in The Journal of pharmacology and experimental therapeutics (01.09.2016)
Get full text
Journal Article
T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice
Terasaka, Naoki, Hiroshima, Ayano, Koieyama, Tadashi, Ubukata, Naoko, Morikawa, Yuka, Nakai, Daisuke, Inaba, Toshimori
Published in FEBS letters (11.02.2003)
Published in FEBS letters (11.02.2003)
Get full text
Journal Article
LXRα regulates human CETP expression in vitro and in transgenic mice
Honzumi, Shoko, Shima, Akiko, Hiroshima, Ayano, Koieyama, Tadashi, Ubukata, Naoko, Terasaka, Naoki
Published in Atherosclerosis (01.09.2010)
Published in Atherosclerosis (01.09.2010)
Get full text
Journal Article
LXRa regulates human CETP expression in vitro and in transgenic mice
Honzumi, Shoko, Shima, Akiko, Hiroshima, Ayano, Koieyama, Tadashi, Ubukata, Naoko, Terasaka, Naoki
Published in Atherosclerosis (01.09.2010)
Published in Atherosclerosis (01.09.2010)
Get full text
Journal Article
COMBINED USAGE OF DIABETES THERAPEUTIC AGENTS
MATSUMOTO, Koji, TAGUCHI, Takashi, UBUKATA, Naoko, TAKAHASHI, Kanako, YOSHITOMI, Tomomi, NAKATSUKA, Yasuhiko
Year of Publication 27.07.2017
Get full text
Year of Publication 27.07.2017
Patent
A novel compound, R-138329, increases plasma HDL cholesterol via inhibition of scavenger receptor BI-mediated selective lipid uptake
Nishizawa, Tomohiro, Kitayama, Ken, Wakabayashi, Kenji, Yamada, Makiko, Uchiyama, Minoru, Abe, Koji, Ubukata, Naoko, Inaba, Toshimori, Oda, Tomiichiro, Amemiya, Yoshiya
Published in Atherosclerosis (01.10.2007)
Published in Atherosclerosis (01.10.2007)
Get full text
Journal Article
LXRalpha regulates human CETP expression in vitro and in transgenic mice
Honzumi, Shoko, Shima, Akiko, Hiroshima, Ayano, Koieyama, Tadashi, Ubukata, Naoko, Terasaka, Naoki
Published in Atherosclerosis (01.09.2010)
Published in Atherosclerosis (01.09.2010)
Get full text
Journal Article
Combination of antidiabetic agents
NAKATSUKA, YASUHIKO, TAKAHASHI, KANAKO, YOSHITOMI, TOMOMI, UBUKATA, NAOKO, MATSUMOTO, KOJI, TAGUCHI, TAKASHI
Year of Publication 16.09.2017
Get full text
Year of Publication 16.09.2017
Patent